Abstract:Neuronal activity robustly drives glioma progression, mediated through paracrine and synaptic neuron-to-glioma interactions. Recent research has focused on glutamatergic and GABAergic neurons, while the impact of neuromodulatory neuron subpopulations and their long-range projections remain unexplored. Here, we explore the glioma-promoting effects of serotonergic and cholinergic brainstem neurons, which project to defined regions throughout the brain. By employing optogenetic stimulation of midbrain serotonergic or cholinergic neurons in mice bearing high-grade glioma allografts or xenografts, we observed robust, circuit-specific effects of each neuromodulatory neuronal subtype on proliferation. Concordant with the anatomy of serotonergic projections, we found that serotonergic neurons of the dorsal raphe nucleus promoted glioma proliferation in the neocortex and pons, while those from the median raphe nucleus increased proliferation in the thalamus. Similarly, stimulation of cholinergic neurons in the laterodorsal tegmentum nucleus enhanced thalamic glioma growth, and stimulation of the pedunculopontine nucleus promoted pontine tumor growth. The long-range neuronal activity-regulated effects on glioma cells were mediated by neurotransmitter secretion at axon terminals, and paracrine signalling protein release locally in the brainstem. The activity-regulated paracrine factor profiles are distinct between serotonergic and cholinergic neurons, illustrating neuron subtype-specific mechanisms affecting glioma cells beyond neurotransmitter differences. Co-culture with hESC/hiPSC-derived cholinergic or serotonergic neurons demonstrated synaptic structures between both neuromodulatory subpopulations and glioma cells, indicating a synaptic component to these neuron-glioma interactions. ScRNA-seq data integration revealed distinct receptor abundances between DMGs and IDH-WT glioblastomas correlating with specific cellular states. Inhibition of these targets – such as M1 or M3 cholinergic receptors in DMG – mitigated the proliferation-inducing effects of the relevant neuron subtype on glioma cells. In summary, these findings introduce brainstem cholinergic and serotonergic neuromodulatory neurons as drivers of high-grade glioma growth in a circuit-specific manner in midline structures and in neocortex, adding to the complexity with which gliomas integrate into brain-wide neural circuitry.

Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA‐Seq

Perivascular NOTCH3+ stem cells drive meningioma tumorigenesis and resistance to radiotherapy

Biom-22. Spatial, Single-Cell, And Bulk Rna Sequencing Identify Molecular Programs Underlying Meningioma Brain Invasion

NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy

MODL-04. ESTABLISHMENT OF TUMOR MICROENVIRONMENT-PRESERVING ORGANOID MODEL FROM PATIENTS WITH INTRACRANIAL MENINGIOMA

Holistic and network analysis of meningioma pathogenesis and malignancy.

MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets

Alteration of FOXM1 expression and macrophage polarization in refractory meningiomas during long-term follow-up

MicroRNA-221/222 Inhibits the Radiation-Induced Invasiveness and Promotes the Radiosensitivity of Malignant Meningioma Cells

Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution

CBX7 Reprograms Metabolic Flux to Protect Against Meningioma Progression by Modulating the USP44/c-MYC/LDHA Axis.

Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome

Cnsc-28. Brainstem Neuromodulatory Neurons Promote Glioma Growth Locally And Via Long-Range Projections To Midline And Cortical Structures

302 Targeted Inhibition of the Epigenetically Activated miR-483-5p IGF-2 Pathway as a Novel Therapeutic Strategy for Meningioma

Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma

Clinical and Prognostic Features of Spinal Meningioma: a Thorough Analysis from a Single Neurosurgical Center.

379 Meningioma Molecular Groups Predict Response to Adjuvant Radiotherapy Following Surgery

Macrophage Membrane‐Coated Nanoparticles Sensitize Glioblastoma to Radiation by Suppressing Proneural–Mesenchymal Transformation in Glioma Stem Cells

Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma

Sequential fate-switches in stem-like cells drive the tumorigenic trajectory from human neural stem cells to malignant glioma

M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-β Signaling Pathway